Insider Trading / SASTClosure of Trading WindowClosure of Trading WindowClosure of Trading WindowFiled 15:51View Source
Company UpdateGeneralMedi-Caps approves reappointment of CMD and appointment of new director at 43rd AGMGovernance changes Re-appointment of Alok K Garg as Chairman and Managing Director; remuneration approved at AGM. Saloni Garg appointed Director and Whole-Time Woman Director; tenure 3 years from 07 Aug 2026. Tenure for Alok Garg is 3 years from 01 Sep 2026 to 31 Aug 2029. Saloni Garg's tenure is 3 years from 07 Aug 2026 to 06 Aug 2029. 43rd AGM was held on 22 September 2026; combined scrutinizer report received on 23 September 2026. Neither director is debarred by SEBI or any authority from acting as a director. Annexure-A disclosure; available on company website and XBRL filing. Filed 16:01View Source
AGM/EGMAGMMedi-Caps AGM approves financials, director reappointments, and Woman Director appointment via VC/OAVMAGM Details AGM conducted in September 2026 through VC/OAVM. Record date for voting entitlements disclosed. Meeting duration reported as a short session. Resolutions & outcomes Ordinary resolution to adopt standalone and consolidated financial statements; approved. Special resolution for re-appointment of Alok Garg as CMD and remuneration; approved. Special resolution to appoint Saloni Garg as Director and Whole-Time Woman Director; approved. Director changes Alok Garg re-appointed as Chairman and Managing Director. Saloni Garg appointed as Director and Whole-Time Woman Director. Filed 15:43View Source
AGM/EGMAGMMedi-Caps 43rd AGM held via VC/OAVM on 22 September 2026; financials adopted and directors appointedAGM Details 43rd AGM held on 22 September 2026 via VC/OAVM. Meeting started 12:30 IST and concluded 12:50 IST. Venue deemed at registered office; meeting conducted via VC/OAVM. Total members on cut-off date: 10,524; members present: 57. Notice dated 6 August 2026 convened the AGM. Remote e-voting window: 19 Sep 2026 9:00 AM to 21 Sep 2026 5:00 PM. Key Resolutions Ordinary: Adoption of standalone and consolidated financial statements for year ended 31 March 2026. Special: Re-appointment of Alok K Garg as CMD; remuneration payable. Special: Confirmation of Saloni Garg as Director and Whole-Time Woman Director. Voting Results Resolution 1: Outcome not disclosed; voting results to be submitted later. Resolution 2: Outcome not disclosed; voting results to be submitted later. Resolution 3: Outcome not disclosed; voting results to be submitted later. Director Changes Alok Garg re-appointed as CMD; remuneration approved. Saloni Garg confirmed as Director and Whole-Time Woman Director. Auditors Statutory auditors present; no change announced. Internal and secretarial auditors attended the meeting. Filed 16:54View Source
Company UpdateNewspaper PublicationSubmission of News paper publication after dispatch of 43rd AGM Notice and Annual Report 2025-26.No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link belowFiled 14:51View Source
AGM/EGMAGMMedi-Caps to hold 43rd AGM via VC/OAVM on 22 September 2026 with 3 resolutions and e-votingAGM Details Date and time: 22 September 2026 at 12:30 PM IST. Mode: VC/OAVM; venue deemed at registered office. Board meeting for Notice approval on 6 August 2026. Total resolutions: 3. E-voting window: 19 Sep 2026 09:00 to 21 Sep 2026 17:00. E-voting cut-off: 15 September 2026. Results to be announced within 2 working days after AGM. Scrutinizer & Governance Scrutinizer: Darshika Wankhede (Practising Company Secretary). Appointment date: 6 August 2026. Filed 12:24View Source
Company UpdateGeneralMedi-Caps sets 43rd AGM date and outlines annual report delivery for non-registered email shareholdersAGM date and delivery framework 43rd AGM and FY2025-26 annual report scheduled for 22 Sep 2026 at 12:30 PM via VC/OAVM. Electronic dispatch to members with registered email; non-registered addresses will receive a physical letter. Annual Report/Notice available at medicaps.com/investorrelation/annual-reports and BSE/CDSL portals. Physical copy requests to investors@medicaps.com with Folio No./DP Id/Client Id. Notice aligns with Companies Act 2013, MCA Circular No. 03/2025 and SEBI Regulations. Letter is a draft for those without registered email; includes web link to full details. Filed 12:17View Source
OthersReg. 34 (1) Annual ReportIntegrated Annual Report 2025-26 of Medi-Caps Limited: Standalone and Consolidated Performance, Governance and Material DevelopmentsFinancial snapshot Standalone total income: 288.24 Lakhs. Standalone revenue from operations: 230.59 Lakhs. Standalone EBITDA: 6.12 Lakhs. Standalone PBT: -12.46 Lakhs. Standalone PAT: -13.87 Lakhs. Standalone EPS: -0.11. Consolidated total revenue: 2065.64 Lakhs. Consolidated PAT: -303.75 Lakhs. Consolidated EPS: -2.44. Dividends: no dividend declared for 2025-26. Capital structure Equity share capital: Rs 12.47 Crore. Promoter stake: Alok Garg 26.21%, Manisha Garg 21.61%. Borrowings: Nil; no debt outstanding. Dematerialisation: 96.77% of shares. Governance & board changes Ramesh Chandra Mittal resigned as Chairman & Director on 06 Aug 2026. Kusum Mittal resigned as Director on 06 Aug 2026. Saloni Garg appointed Additional Director & Whole-Time Woman Director from 07 Aug 2026. Alok K Garg re-appointed Chairman & Managing Director for three years from 01 Sep 2026. Subsidiaries & related party Medgel Private Limited is a material subsidiary; 100% holding. Medgel turnover: 1014.26 Lakhs; investment in Medgel: 4282.35 Lakhs. Major related party transactions include MD remuneration Rs 84.00 Lakhs; CFO remuneration Rs 30.00 Lakhs; Saloni Garg Rs 24.00 Lakhs. End-year related party balances: MD Rs 7.00; Akshit Garg Rs 2.50; Saloni Garg Rs 2.00; Abhishek Jain Rs 0.70; Hemant Sethi Rs 1.95. Audit, controls & compliance Statutory auditor: Rawka & Associates; Secretarial: Joshi Sahay; Internal: Praveen Shrivastava. Secretarial MR-3; historical charges flagged; ROC follow-up ongoing. Internal financial controls are adequate and effective. 2023-24 penalty: Rs 5,900 for delayed related party disclosure. Outlook & risks Management focuses on real estate; project pipeline and prudent cost control. Market conditions impact near-term performance; ongoing liquidity management. Shareholder information & AGM 43rd AGM scheduled 22 Sep 2026 via VC/OAVM. Cut-off date 15 Sep 2026; remote e-voting 19-21 Sep 2026. Top holders: Alok Garg 26.21%, Manisha Garg 21.61%, Sangeetha S 5.55%. Filed 12:09View Source
AGM/EGMAGMMedi Caps to hold 43rd AGM via VC/OAVM on 22 Sep 2026 with director and remuneration proposals.AGM Details Date/time: 22 September 2026 at 12:30 IST. Mode: VC/OAVM; venue at registered office. Ordinary Business Adopt standalone financial statements for year ended 31 March 2026. Adopt consolidated financial statements for year ended 31 March 2026. Special Businesses Re-appointment of Alok Garg as CMD for three years at Rs 7.00 Lakh per month. Appointment of Saloni Garg as Whole-Time Woman Director for three years at Rs 2.00 Lakh per month. Confirmation of Saloni Garg as Director and Whole-Time Woman Director. Perquisites capped at 25% of annual salary. Director Changes Ramesh Chandra Mittal resigned as Chairman and Director on 06 Aug 2026. Alok K Garg appointed Chairman and Managing Director from 01 Sep 2026. Saloni Garg appointed Additional Director on 07 Aug 2026. Filed 11:47View Source
Company UpdateNewspaper PublicationSubmission of Newspaper publication regarding information of 43rd Annual General Meeting before dispatch of notice and Annual Report 2025-26No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link belowFiled 15:38View Source